News

xFOREST Therapeutics Achieves A Milestone in Drug Discovery Collaboration with Otsuka

xFOREST Therapeutics (Headquarter: Sakyo-ku, Kyoto, Japan; President and CEO: Shunichi Kashida; hereinafter, xFOREST) is pleased to announce the achievement of a milestone as drug discovery collaboration with Otsuka to target RNA structures. This project was initiated on June 13, 2022. As a result of this achievement, xFOREST will receive a milestone payment.